Psychiatry · Kansas City, MO
NPI
1720169295
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3801 Blue Pkwy
Kansas City, MO, 64130
Phone (816) 922-7645
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,894
71 services
Medicare patients, 2024
31
Average age 50
Drug cost, 2024
$1.8M
7,470 prescriptions
Company payments, 2025
$3,377
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark Cannon was code 99213 (office e&m - established), 58 times for 27 patients. In total Mark Cannon billed 71 services in 3 codes, and Medicare paid $1,894.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 58 | 27 | $23.32 | $1,353 |
By year: 2022 $3,528 for 139 services; 2023 $3,466 for 152 services; 2024 $1,894 for 71 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark Cannon prescribed most often to Medicare patients was Quetiapine Fumarate, with 501 prescriptions and refills. In total Mark Cannon wrote 7,470 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Quetiapine Fumarate Generic | 501 | 584 | 55 | $15K |
| Diazepam Generic | 422 | 422 | 53 | $3,674 |
| Trazodone Hcl Generic | 389 | 450 | 53 | $4,747 |
| Clonazepam Generic | 343 | 345 | 51 | $4,794 |
| Benztropine Mesylate Generic | 313 | 336 | 40 | $3,766 |
| Olanzapine Generic | 279 | 315 | 34 | $6,469 |
| Risperidone Generic | 255 | 268 | 30 | $7,876 |
| Fluoxetine Hcl Generic | 252 | 263 | 28 | $5,961 |
| Aripiprazole Generic | 216 | 257 | 34 | $14K |
| Lorazepam Generic | 192 | 198 | 39 | $2,560 |
| Duloxetine Hcl Generic | 185 | 206 | 30 | $2,806 |
| Rexulti Brexpiprazole | 174 | 190 | 28 | $292K |
| Sertraline Hcl Generic | 154 | 170 | 23 | $1,450 |
| Citalopram Hbr Citalopram Hydrobromide | 143 | 158 | 15 | $1,258 |
| Hydroxyzine Pamoate Generic | 142 | 142 | 27 | $2,049 |
Brand drugs: 810 claims; generic drugs: 6,660 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark Cannon $3,377 ($3,377 in general payments such as food, travel and fees) from 14 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $529.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 45 | $529 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 27 | $410 |
| Abbvie Inc. ABBV | 41 | $397 |
| Alkermes, Inc. ALKS | 20 | $363 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 21 | $327 |
| Neurocrine BioSciences, Inc. NBIX | 15 | $323 |
| Vanda Pharmaceuticals Inc. VNDA | 34 | $320 |
| Axsome Therapeutics, Inc. AXSM | 16 | $211 |
| Janssen Pharmaceuticals, Inc JNJ | 10 | $200 |
| Teva Pharmaceuticals USA, Inc. TEVA | 17 | $173 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.